Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Clinical trial NCT01783197 · COMPLETED
Trial details
- NCT number
- NCT01783197
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-04
- Primary completion
- 2017-04-18
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.